Atai Life Sciences logo

Atai Life Sciences

ATAI • NASDAQ

Atai Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Srinivas G. Rao, with a market cap of $1.3B.

Market Cap$1.3B
Employees83.0
CEOSrinivas G. Rao
CountryGermany
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
Atai Life Sciences logo

Atai Life Sciences FAQ

Common questions about Atai Life Sciences

Atai Life Sciences is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $90.9K.

Atai Life Sciences has approximately 83 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Atai Life Sciences (ATAI) Q1 2026 Earnings - OpenCapital